…
UK listed Target Healthcare REIT plc (THRL) is an externally managed FTSE 250 Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes. The Group's portfolio at 30 September 2025 comprised 93 assets let to 32 tenants with a total value of 948.3 million. The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Income before tax | 60.84M | 73.02M | -6.57M | 49.10M | 43.88M |
| Net income | 60.84M | 73.02M | -6.57M | 49.10M | 43.88M |
| Selling general administrative | - | 2.70M | 2.63M | 2.68M | 2.37M |
| Selling and marketing expenses | - | 0.18M | 0.23M | 0.33M | 0.21M |
| Gross profit | 64.84M | 78.48M | -3.26M | 55.50M | 49.21M |
| Ebit | - | 73.02M | 55.77M | 55.77M | 38.85M |
| Ebitda | 59.59M | 58.00M | -6.57M | 49.10M | 43.89M |
| Depreciation and amortization | - | - | -0.57M | -0.57M | - |
| Operating income | 59.59M | 73.02M | -6.57M | 49.10M | 43.89M |
| Other operating expenses | 13.34M | 5.46M | 64.88M | 8.16M | 1.29M |
| Interest expense | - | 10.24M | 10.27M | 6.67M | 5.76M |
| Tax provision | - | 0.00M | 0.00M | 0.01M | -0.01M |
| Interest income | - | 0.07M | 0.13M | 0.07M | 0.04M |
| Net interest income | - | -10.18M | -10.14M | -6.60M | -4.24M |
| Income tax expense | - | - | 0.01M | 0.01M | -0.01M |
| Total revenue | 72.93M | 78.48M | -3.26M | 55.50M | 49.21M |
| Total operating expenses | - | 5.46M | 3.31M | 6.39M | 5.33M |
| Cost of revenue | 8.08M | 7.72M | - | - | - |
| Total other income expense net | 1.25M | 4.43M | -6.57M | 49.10M | 43.88M |
| Net income from continuing ops | - | 73.02M | -6.57M | 49.10M | 43.88M |
| Net income applicable to common shares | - | - | -6.57M | 49.10M | 43.88M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Total assets | 986.19M | 967.37M | 908.26M | 963.66M | 718.39M |
| Other current assets | -131.40M | -111.41M | 13.20M | 7.70M | 7.32M |
| Total liab | 273.73M | 278.08M | 253.45M | 264.89M | 153.21M |
| Total stockholder equity | 712.46M | 689.29M | 654.81M | 698.77M | 565.18M |
| Other current liab | -91.85M | 16.19M | -18.31M | -26.36M | -18.46M |
| Common stock | 6.20M | 6.20M | 6.20M | 6.20M | 5.12M |
| Capital stock | - | 6.20M | 6.20M | 6.20M | 5.12M |
| Retained earnings | 187.30M | 176.70M | 298.28M | 302.15M | 312.73M |
| Other liab | - | - | 8.09M | 7.14M | 6.84M |
| Other assets | 986.19M | 967.37M | 92.74M | 71.48M | 66.13M |
| Cash | 39.53M | 38.88M | 15.37M | 34.48M | 21.11M |
| Total current liabilities | - | 18.47M | 18.31M | 26.36M | 18.46M |
| Net debt | 200.76M | 201.79M | 211.69M | 196.90M | 106.80M |
| Short term debt | 91.85M | - | - | - | - |
| Short long term debt total | 240.29M | 240.67M | 227.05M | 231.38M | 127.90M |
| Other stockholder equity | 256.63M | 256.63M | -304.48M | -308.35M | -317.84M |
| Property plant equipment | - | - | 800.15M | 857.69M | 629.61M |
| Total current assets | - | 143.76M | 15.37M | 34.48M | 21.11M |
| Long term investments | - | 2.82M | 6.91M | 2.28M | 0.25M |
| Net tangible assets | - | - | 654.81M | 698.77M | 565.18M |
| Short term investments | 0.11M | 0.08M | - | - | - |
| Net receivables | 91.76M | 94.09M | 85.83M | 69.20M | 60.11M |
| Inventory | - | 122.19M | - | - | - |
| Accounts payable | - | 2.27M | 18.31M | 26.36M | 18.46M |
| Accumulated other comprehensive income | 262.32M | 249.76M | - | - | - |
| Non currrent assets other | - | -2.82M | -6.91M | -2.28M | -0.25M |
| Non current assets total | - | 2.82M | 800.15M | 857.69M | 631.16M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Investments | - | 3.42M | -3.55M | -202.63M | -43.58M |
| Change to liabilities | - | - | -0.33M | 4.59M | 1.86M |
| Total cashflows from investing activities | -3.23M | 3.42M | -3.55M | -202.63M | -43.58M |
| Net borrowings | - | 13.00M | -4.75M | 104.75M | -22.00M |
| Total cash from financing activities | -37.11M | -22.24M | -45.23M | 185.62M | 3.29M |
| Change to operating activities | - | - | - | -1.25M | -1.55M |
| Net income | 60.84M | 73.02M | -6.57M | 49.10M | 43.88M |
| Change in cash | 0.73M | 23.52M | -19.12M | 13.38M | -15.33M |
| Begin period cash flow | 38.80M | 15.37M | 34.48M | 21.11M | 36.44M |
| End period cash flow | 39.53M | 38.88M | 15.37M | 34.48M | 21.11M |
| Total cash from operating activities | 41.10M | 42.34M | 29.66M | 30.39M | 24.96M |
| Issuance of capital stock | - | - | 0.00M | 125.00M | 60.00M |
| Depreciation | - | - | - | - | 0.04M |
| Other cashflows from investing activities | - | 44.34M | - | - | 0.15M |
| Dividends paid | 36.11M | 35.24M | 40.27M | 39.78M | 31.49M |
| Change to account receivables | 1.37M | 3.08M | -4.55M | -3.77M | -1.23M |
| Sale purchase of stock | - | - | - | -7.75M | 114.00M |
| Other cashflows from financing activities | - | 3.42M | 61.80M | 225.40M | 34.78M |
| Change to netincome | - | - | 40.49M | -18.84M | -18.58M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.71M |
| Change in working capital | 2.01M | 5.17M | -4.88M | -0.43M | -0.92M |
| Other non cash items | -21.76M | -35.85M | 41.11M | -18.28M | -18.00M |
| Free cash flow | 41.10M | 42.34M | 29.66M | 30.39M | 24.96M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| THRL Target Healthcare REIT Ltd |
1.40 1.20% |
117.80 | 8.09 | 15.72 | 8.75 | 0.89 | 10.23 | 26.25 |
| PHP Primary Health Properties |
0.85 0.92% |
93.05 | 13.53 | 12.52 | 9.49 | 0.94 | 25.47 | - |
UK listed Target Healthcare REIT plc (THRL) is an externally managed FTSE 250 Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes. The Group's portfolio at 30 September 2025 comprised 93 assets let to 32 tenants with a total value of 948.3 million. The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.
Level 4 Dashwood House, London, United Kingdom, EC2M 1QS
44 1786 845 912
| Name | Title | Year Born |
|---|---|---|
| Mr. Kenneth Macangus MacKenzie C.A., M.A., MA CA | Founder & Chief Exec. of Target Fund Mang.s Limited | 1950 |
| Mr. Gordon Bland BAcc CA, C.A. | Fin. Director of Target Fund Mang.s Limited | NA |
| Mr. John Flannelly BAcc FCA, F.C.A. | Head of Investment - Target Fund Mang.s Limited | NA |
| Mr. Andrew Brown | Head of Healthcare - Target Fund Mang.s Limited | NA |
| Mr. Scott Steven M.A. | Head of Asset Management - Target Fund Mang.s Limited | NA |
| Mr. Donald Cameron B.Com., C.A. | Company Sec. & Director of Financial Reporting - Target Fund Mang.s Limited | NA |
| Mr. Kenneth Macangus MacKenzie C.A., M.A., M.B.E. | Founder & Chief Executive of Target Fund Managers Limited | 1950 |
| Mr. Alastair Murray | Chief Financial Officer - Target Fund Managers Limited | NA |
| Mr. John Flannelly BAcc FCA, F.C.A. | Head of Investment - Target Fund Managers Limited | NA |
| Mr. James Mackenzie L.L.B. | Head of Investor Relations - Target Fund Managers Limited | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.